Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
11 Jun, 2026, 09.05 PM IST
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
11 Jun, 2026, 11.48 AM IST
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
11 Jun, 2026, 10.24 AM IST
Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
10 Jun, 2026, 02.14 PM IST
Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
10 Jun, 2026, 07.08 AM IST
Stock Radar: HCC stock breaks out from a triangle formation; time to buy?Hindustan Construction Company Ltd (HCC) stock has broken out of a triangular pattern, signaling potential for upward movement. Experts sug...
10 Jun, 2026, 05.00 AM IST
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
09 Jun, 2026, 07.34 PM IST
SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
09 Jun, 2026, 03.15 PM IST
Buy, Sell or Hold: Morgan Stanley maintains underweight on Wipro; HDFC Securities upgrades Stylam IndustriesBrokerages remain selective on Indian equities, with Morgan Stanley maintaining an underweight stance on Wipro due to growth concerns. HDFC...
08 Jun, 2026, 09.34 AM IST
Bitcoin price target: World's largest cryptocurrency could hit $100,000 even after June's crash but there is a warning too, says top crypto analystBitcoin price today: The biggest crypto token has tumbled more than 15 per cent since Monday.
04 Jun, 2026, 07.33 PM IST
UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasonsUBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...
04 Jun, 2026, 11.56 AM IST
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
02 Jun, 2026, 03.30 PM IST
Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
01 Jun, 2026, 09.23 PM IST
Bearish move or buying opportunity? Geojit's Anand James on Nifty levels and top stocks to watchMarket volatility surged following a late-Friday sell-off, with MSCI rebalancing and global cues cited as triggers. Geojit Financial Servic...
01 Jun, 2026, 09.00 AM IST
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
31 May, 2026, 01.34 PM IST
Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
29 May, 2026, 04.03 PM IST